Spots Global Cancer Trial Database for Microwave Ablation in the Treatment of Stage I Non Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Microwave Ablation in the Treatment of Stage I Non Small Cell Lung Cancer
Official Title: Microwave Ablation in the Treatment of Stage I Non Small Cell Lung Cancer
Study ID: NCT02896166
Conditions
Interventions
Study Description
Brief Summary: Lung cancer, the leading cause of cancer related mortality. Among them, non small cell lung cancer accounts for 85%. Only part of patients could be treated with radical surgery, and some patients were unfit for surgery due to the poor cardio-pulmonary function or refuse surgery. For those patients, microwave ablation (MWA) could be an alternative treatment. Several small sample retrospective studies verified that MWA could be an efficacy and safe treatment.
Detailed Description: Patients with stage I non small cell lung cancer unfit for or refused surgery will be treated with MWA in the primary tumor sites.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Shandong Provincial Hospital, Jinan, Shandong, China
Shandong Provincial Hospital affliated to Shandong University, Jinan, Shandong, China
Contact Details
Name: Xin Ye, M.D.
Affiliation: Shandong Provincial Hospital affliated to Shandong University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
